
|Videos|December 9, 2020
Dr. Katie Murray on the challenges of treating low-grade UTUC
Author(s)Urology Times staff
Murray also discusses the low-grade upper tract urothelial cancer treatment mitomycin-containing reverse thermal gel (Jelmyto).
Advertisement
In this video, Katie Murray, DO, explains what makes low-grade upper tract urothelial cancer difficult to treat and also discusses mitomycin-containing reverse thermal gel (Jelmyto). Murray is an assistant professor of surgery-urology at the University of Missouri, Columbia.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











